Assessment of bioequivalence of a generic cyclosporine (Equoral™) by a prospective randomised contro...
Assessment of bioequivalence of a generic cyclosporine (Equoral™) by a prospective randomised controlled trial in allogeneic stem cell transplant (ASCT) recipients
About this item
Full title
Author / Creator
Abdelkefi, A , Torjeman, L , Lakhal, A , Othman, T. Ben , Lakhal, M , Klouz, A , Ladeb, S and Fredj, N. Ben
Publisher
Nature Publishing Group
Journal title
Language
English
Formats
Publication information
Publisher
Nature Publishing Group
Subjects
More information
Scope and Contents
Contents
Introduction: The bioequivalence of Equoral has been established by measuring pharmacokinetic parameters in healthy volunteers and in stable renal transplant recipients. To our knowledge, no study was performed in ASCT recipients. The aim of our study is to compare the pharmacokinetics and safety of Equoral solution (IVAX, USA) to Neoral solution (...
Alternative Titles
Full title
Assessment of bioequivalence of a generic cyclosporine (Equoral™) by a prospective randomised controlled trial in allogeneic stem cell transplant (ASCT) recipients
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_gale_healthsolutions_A198170371
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_gale_healthsolutions_A198170371
Other Identifiers
ISSN
0268-3369
